These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6171518)

  • 1. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains.
    Ochanda JO; Syuto B; Oguma K; Iida H; Kubo S
    Appl Environ Microbiol; 1984 Jun; 47(6):1319-22. PubMed ID: 6204594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.
    Oguma K; Agui T; Syuto B; Kimura K; Iida H; Kubo S
    Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diversity of neurotoxins from Clostridium botulinum type D strains.
    Moriishi K; Syuto B; Kubo S; Oguma K
    Infect Immun; 1989 Sep; 57(9):2886-91. PubMed ID: 2668193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneities of two components of C2 toxin produced by Clostridium botulinum types C and D.
    Ohishi I; Okada Y
    J Gen Microbiol; 1986 Jan; 132(1):125-31. PubMed ID: 3086490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
    Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
    Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin.
    Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G
    Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Miyazaki S; Sakaguchi G
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies.
    Oguma K; Murayama S; Syuto B; Iida H; Kubo S
    Infect Immun; 1984 Feb; 43(2):584-8. PubMed ID: 6198281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component.
    Mahmut N; Inoue K; Fujinaga Y; Arimitsu H; Sakaguchi Y; Hughes L; Hirst R; Murphy T; Tsuji T; Watanabe T; Ohyama T; Karasawa T; Nakamura S; Yokota K; Oguma K
    J Med Microbiol; 2002 Oct; 51(10):813-820. PubMed ID: 12435059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
    Tsuzuki K; Yokosawa N; Syuto B; Ohishi I; Fujii N; Kimura K; Oguma K
    Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 20. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.